1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Ophthalmology Devices Global Market – Forecast To 2021

Ophthalmology Devices Global Market – Forecast To 2021

  • July 2015
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 328 pages

Ophthalmology is a segment of medical science associated with study of anatomy, physiology, diseases of human eye, and developing various therapeutic methods to treat eye diseases. Some of the major eye diseases are either age-related or caused due to chronic disorders. They include various degenerative eye diseases like macular degeneration, cataract, ocular hypertension (glaucoma), and refractive errors among others. Revolution in the field of medical science has led to the rapid development of ophthalmology devices that are invented to effectively treat ocular defects and disorders.

Ophthalmology devices market is segmented on the basis of products type as diagnostic devices, surgical devices and vision care. Based on the applications the ophthalmology devices market is segmented into cataract, glaucoma, age-related macular degeneration, diabetes retinopathy and others (refractive errors, amblyopia, and strabismus). End-users are segmented into hospitals, academic and research laboratories, and others (private eye clinic and vision care outlets).

The global ophthalmology devices market is expected to grow at a CAGR of around 5.8% from 2015 to 2021. Increasing incidence of degenerative diseases of eyes, increasing baby boomer population, increase in R&D activities in ophthalmology key players and extensive use of high-end technologies involving use of software and computer aided devices and platforms in ophthalmology drives the market of ophthalmology devices market. Lack of ophthalmologists, economic slowdown and saturation of the market in developed countries are the factors hampering the market growth.

Lifestyle changes owing to increase in ocular cancer, diabetes and macular degeneration patients, early diagnosis and treatment of diseases, advancement of technology with its wide application areas shows that ophthalmology devices market has vast opportunities in the coming years.

North America accounts for the highest market share followed by Europe. Steep rise in ageing population, increase in minimally invasive surgeries and favourable government policies makes U.S. the leader of ophthalmology devices market. However, Asian countries especially India and China’s are the fast growing regions with its growing demand for ophthalmology devices and increasing research investments.

Major players in ophthalmology devices market include Abbott Medical Optics, Inc. (U.S.), Alcon Laboratories, Inc. (U.S.), Bausch & Lomb, Inc. (U.S.), Carl Zeiss (Germany), Essilor International SA (U.S.), Haag-Streit Holding AG (Switzerland), Hoya Corporation (Japan), Nidek Co. Ltd (Japan), STAAR Surgicals (U.S.) and Topcon Corporation (Japan).

Table Of Contents

Ophthalmology Devices Global Market - Forecast To 2021
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 20
2 INTRODUCTION 27
2.1 KEY TAKE AWAYS 27
2.2 REPORT DESCRIPTION 28
2.3 MARKETS COVERED 29
2.4 STAKEHOLDERS 32
2.5 RESEARCH METHODOLOGY 32
2.5.1 MARKET SIZE ESTIMATION 34
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 36
2.5.3 SECONDARY SOURCES 37
2.5.4 PRIMARY SOURCES 38
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 38
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 39
2.5.7 ASSUMPTIONS 40
3 MARKET ANALYSIS 41
3.1 INTRODUCTION 41
3.2 MARKET SEGMENTATION 42
3.3 FACTORS INFLUENCING MARKET 44
3.3.1 DRIVERS 45
3.3.1.1 Increasing baby boomer population and incidence of degenerative diseases of eyes 45
3.3.1.2 Increase in randd activities by ophthalmology key players 45
3.3.1.3 Extensive use of high-end technologies involving use of software and computer aided devices and platforms 46
3.3.1.4 Untapped emerging markets 46
3.3.1.5 Development of minimal invasive surgery 47
3.3.2 RESTRAINTS 47
3.3.2.1 Lack of ophthalmologists 47
3.3.2.2 Economic slowdown and saturation of the market in developed
countries 48
3.3.2.3 Reimbursement cuts 48
3.3.3 THREATS 49
3.3.3.1 Intensified competition 49
3.3.4 CHALLENGES 49
3.3.4.1 Lack of insurance coverage in developing countries and insufficient coverage for iols in developed countries 49
3.3.4.2 Extended timelines of device approval 50
3.4 REGULATORY AFFAIRS 51
3.4.1 U.S. 51
3.4.2 EUROPE 52
3.4.3 CHINA 52
3.4.4 INDIA 53
3.4.5 JAPAN 53
3.5 REIMBURSEMENT SCENARIO 54
3.5.1 REIMBURSEMENT TABLE 55
3.6 PATENT TRENDS 58
3.7 TECHNOLOGICAL ADVANCEMENTS 61
3.8 UPCOMING TECHNOLOGIES 63
3.9 PORTER'S FIVE FORCE ANALYSIS 69
3.9.1 THREAT OF NEW ENTRANTS 70
3.9.2 THREAT OF SUBSTITUTES 70
3.9.3 RIVALRY AMONG EXISTING COMPETITORS 71
3.9.4 BARGAINING POWER OF SUPPLIERS 71
3.9.5 BARGAINING POWER OF BUYERS 71
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 72
4 GLOBAL OPHTHALMOLOGY DEVICES MARKET, BY PRODUCTS 75
4.1 INTRODUCTION 75
4.1.1 GLOBAL OPHTHALMOLOGY DIAGNOSTIC DEVICES BY PRODUCT TYPES 76
4.1.1.1 Autorefractors 80
4.1.1.2 Slit lamp 82
4.1.1.3 Tonometer 84
4.1.1.4 Ophthalmoscope 86
4.1.1.5 Keratometer 88
4.1.1.6 Corneal topographer 90
4.1.1.7 Optical coherence tomography (OCT) 92
4.1.1.8 Fundus camera 94
4.1.1.8.1 Non-mydriatic fundus cameras 98
4.1.1.8.2 Mydriatic fundus cameras 99
4.1.1.8.3 Hybrid fundus cameras 100
4.1.1.8.4 Retinopathy of prematurity (ROP) 102
4.1.1.9 Ophthalmic ultrasound imaging system 103
4.1.1.10 Retinoscope 105
4.1.1.11 Perimeter 107
4.1.1.12 Pachymeter 109
4.1.1.13 Others 111
4.1.1.13.1 Snellen chart 112
4.1.1.13.2 Amsler grid eye test 112
4.1.1.13.3 Wavefront aberrometer 113
4.1.1.13.4 Point of care devices 113
4.1.2 GLOBAL OPHTHALMIC SURGICAL DEVICES MARKET 115
4.1.2.1 Introduction 115
4.1.2.2 Cataract surgery devices 119
4.1.2.2.1 Intraocular lens (IOL) 122
4.1.2.2.2 Phacoemulsification 125
4.1.2.2.3 OVDS (OPHTHALMIC VISCOSURGICAL DEVICES) 127
4.1.2.2.4 YAG Laser 129
4.1.2.3 Glaucoma surgery devices 129
4.1.2.3.1 Glaucoma lasers 131
4.1.2.3.2 Glaucoma surgery 131
4.1.2.3.3 Glaucoma implants 131
4.1.2.3.4 Glaucoma systems 132
4.1.2.4 Refractive error surgical devices 132
4.1.2.4.1 Photorefractive keratectomy (PRK) 134
4.1.2.4.2 Laser assisted sub-epithelium keratomileusis (LASEK) 134
4.1.2.4.3 Laser assisted insitu keratomileusis (LASIK) 134
4.1.2.4.4 Femtosecond laser 134
4.1.2.4.5 Epi-LASIK 135
4.1.2.4.6 Phakic intraocular lens (PIOLS) 136
4.1.2.5 Vitreoretinal surgical devices 136
4.1.2.5.1 Vitrectomy 137
4.1.2.5.2 Photocoagulation 138
4.1.2.5.3 Illumination 138
4.1.3 GLOBAL VISION CARE DEVICES 139
4.1.3.1 Introduction 139
4.1.3.2 Spectacle lenses 142
4.1.3.3 Contact lenses 144
5 OPHTHALMOLOGY DEVICES GLOBAL MARKET, BY APPLICATIONS 147
5.1 INTRODUCTION 147
5.2 CATARACT 150
5.3 GLAUCOMA 153
5.4 AGE RELATED MACULAR DEGENERATION 155
5.5 DIABETIC RETINOPATHY (DR) 157
5.6 OTHERS (REFRACTIVE ERRORS, AMBLYOPIA, STRABISMUS) 160
6 OPHTHALMOLOGY DEVICES GLOBAL MARKET, BY END-USERS 162
6.1 INTRODUCTION 162
6.2 HOSPITALS 165
6.3 ACADEMIC and RESEARCH LABORATORIES 167
6.4 OTHERS 169
7 REGIONAL ANALYSIS 171
7.1 INTRODUCTION 171
7.2 NORTH AMERICA 173
7.2.1 U.S. 174
7.2.2 CANADA 175
7.3 EUROPE 185
7.4 ASIA PACIFIC 195
7.5 REST OF THE WORLD 205
8 COMPANY DEVELOPMENTS 215
8.1 INTRODUCTION 215
8.2 NEW PRODUCT LAUNCHES 216
8.3 AGREEMENTS, PARTNERSHIP, COLLABORATION and JOINT VENTURES 222
8.4 APPROVALS 225
8.5 MERGERS and ACQUISITIONS 229
9 MAJOR COMPANIES 232
9.1 ABBOTT LABORATORIES 232
9.1.1 OVERVIEW 232
9.1.2 FINANCIALS 233
9.1.3 PRODUCT PORTFOLIO 236
9.1.4 KEY DEVELOPMENTS 240
9.1.5 BUSINESS STRATEGY 241
9.1.6 SWOT ANALYSIS 242
9.2 NOVARTIS AG 243
9.2.1 OVERVIEW 243
9.2.2 FINANCIALS 244
9.2.3 PRODUCT PORTFOLIO 247
9.2.4 KEY DEVELOPMENTS 249
9.2.5 BUSINESS STRATEGY 251
9.2.6 SWOT ANALYSIS 251
9.3 VALEANT PHARMACEUTICALS INTERNATIONAL, INC 252
9.3.1 OVERVIEW 252
9.3.2 FINANCIALS 253
9.3.3 PRODUCT PORTFOLIO 255
9.3.4 KEY DEVELOPMENTS 258
9.3.5 BUSINESS STRATEGY 262
9.3.6 SWOT ANALYSIS 263
9.4 CARL ZEISS AG 264
9.4.1 OVERVIEW 264
9.4.2 FINANCIALS 265
9.4.3 PRODUCT PORTFOLIO 268
9.4.4 KEY DEVELOPMENTS 273
9.4.5 BUSINESS STRATEGY 274
9.4.6 SWOT ANALYSIS 275
9.5 ESSILOR INTERNATIONAL 276
9.5.1 OVERVIEW 276
9.5.2 FINANCIALS 277
9.5.3 PRODUCTS PORTFOLIO 279
9.5.4 KEY DEVELOPMENTS 281
9.5.5 BUSINESS STRATEGY 285
9.5.6 SWOT ANALYSIS 285
9.6 HAAG-STREIT HOLDING AG. 286
9.6.1 OVERVIEW 286
9.6.2 FINANCIALS 287
9.6.3 PRODUCT PORTFOLIO 287
9.6.4 KEY DEVELOPMENTS 290
9.6.5 BUSINESS STRATEGY 290
9.6.6 SWOT ANALYSIS 291
9.7 HOYA CORPORATION 292
9.7.1 OVERVIEW 292
9.7.2 FINANCIALS 293
9.7.3 PRODUCTS PORTFOLIO 296
9.7.4 KEY DEVELOPMENTS 297
9.7.5 BUSINESS STRATEGY 297
9.7.6 SWOT ANALYSIS 298
9.8 JOHNSON and JOHNSON 299
9.8.1 OVERVIEW 299
9.8.2 FINANCIALS 300
9.8.3 PRODUCT PORTFOLIO 303
9.8.4 KEY DEVELOPMENTS 304
9.8.5 BUSINESS STRATEGY 304
9.8.6 SWOT ANALYSIS 305
9.9 NIDEK CO., LTD 306
9.9.1 OVERVIEW 306
9.9.2 FINANCIALS 306
9.9.3 PRODUCT PORTFOLIO 307
9.9.4 KEY DEVELOPMENTS 310
9.9.5 BUSINESS STRATEGY 312
9.10 STAAR SURGICAL COMPANY 313
9.10.1 OVERVIEW 313
9.10.2 FINANCIALS 314
9.10.3 PRODUCT PORTFOLIO 317
9.10.4 KEY DEVELOPMENTS 317
9.10.5 BUSINESS STRATEGY 318
9.10.6 SWOT ANALYSIS 319
9.11 TOPCON CORPORATION 320
9.11.1 OVERVIEW 320
9.11.2 FINANCIALS 321
9.11.3 PRODUCT PORTFOLIO 324
9.11.4 KEY DEVELOPMENTS 326
9.11.5 BUSINESS STRATEGY 326
9.11.6 SWOT ANALYSIS 327

LIST OF TABLES

TABLE 1 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 23
TABLE 2 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN) 24
TABLE 3 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2013-2021) ($MN) 25
TABLE 4 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2013-2021) ($MN) 26
TABLE 5 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN) 76
TABLE 6 DIAGNOSTIC DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 78
TABLE 7 AUTOREFRACTOMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 81
TABLE 8 SLIT LAMP GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 83
TABLE 9 TONOMETERS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 85
TABLE 10 OPHTHALMOSCOPE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 87
TABLE 11 KERATOMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 89
TABLE 12 CORNEAL TOPOGRAPHER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 91
TABLE 13 OPTICAL COHERENCE TOMOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 93
TABLE 14 FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 96
TABLE 15 FUNDUS CAMERA GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 97
TABLE 16 NON-MYDRIATIC FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 98
TABLE 17 MYDRIATIC FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 100
TABLE 18 HYBRID FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 101
TABLE 19 RETINOPATHY OF PREMATURITY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 102
TABLE 20 OPHTHALMIC ULTRASOUND IMAGING SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 104
TABLE 21 RETINOSCOPE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 106
TABLE 22 PERIMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 108
TABLE 23 PACHYMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 110
TABLE 24 OTHERS (DIAGNOSTICS) GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 111
TABLE 25 SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 116
TABLE 26 SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 117
TABLE 27 CATARACT SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 120
TABLE 28 CATARACT SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 121
TABLE 29 IOL GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 124
TABLE 30 PHACOEMULSIFICATION GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 126
TABLE 31 OVD GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 128
TABLE 32 GLACOMA SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 130
TABLE 33 REFRACTIVE SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 133
TABLE 34 VITREORETINAL SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 137
TABLE 35 VISION CARE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 140
TABLE 36 VISION CARE GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 141
TABLE 37 SPECTACLE LENSES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 143
TABLE 38 CONTACT LENSES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 146
TABLE 39 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 149
TABLE 40 CATARACT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 152
TABLE 41 GLAUCOMA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 154
TABLE 42 AGE RELATED MACULAR DEGENERATION MARKET REVENUE, BY REGION, (2013-2021) ($MN) 156
TABLE 43 DIABETIC RETINOPATHY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 159
TABLE 44 OTHERS (APPLICATIONS) GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 161
TABLE 45 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2013-2021) ($MN) 164
TABLE 46 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 166
TABLE 47 ACADEMICS and RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 168
TABLE 48 OTHER END USERS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 170
TABLE 49 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN) 177
TABLE 50 NORTH AMERICAN DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 178
TABLE 51 NORTH AMERICAN FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 179
TABLE 52 NORTH AMERICAN SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 180
TABLE 53 NORTH AMERICAN CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 181
TABLE 54 NORTH AMERICAN VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 182
TABLE 55 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 183
TABLE 56 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USER, (2013-2021) ($MN) 184
TABLE 57 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 187
TABLE 58 EUROPEAN DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 188
TABLE 59 EUROPEAN FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 189
TABLE 60 EUROPEAN SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 190
TABLE 61 EUROPEAN CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 191
TABLE 62 EUROPEAN VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 192
TABLE 63 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 193
TABLE 64 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN) 194
TABLE 65 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 197
TABLE 66 ASIA-PACIFIC DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 198
TABLE 67 ASIA-PACIFIC FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 199
TABLE 68 ASIA-PACIFIC SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 200
TABLE 69 ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 201
TABLE 70 ASIA-PACIFIC VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 202
TABLE 71 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 203
TABLE 72 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN) 204
TABLE 73 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE (2013-2021) ($MN) 207
TABLE 74 ROW DIAGNOSTICS DEVICES MARKET REVENUE, BY TYPES, (2013-2021) ($MN) 208
TABLE 75 ROW FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 209
TABLE 76 ROW SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 210
TABLE 77 ROW CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 211
TABLE 78 ROW VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 212
TABLE 79 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 213
TABLE 80 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN) 214
TABLE 81 NEW PRODUCT LAUNCHES (2013-2015) 217
TABLE 82 AGREEMENTS, PARTNERSHIP, COLLABORATION and JOINT VENTURES (2013-2015) 222
TABLE 83 APPROVALS (2013-2015) 226
TABLE 84 MERGERS and ACQUISITIONS (2013-2015) 229
TABLE 85 ABBOTT LABORATORIES: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 233
TABLE 86 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 234
TABLE 87 ABBOTT LABORATORIES: REVENUE SEGMENTS OF MEDICAL DEVICES, (2013-2014)($MN) 235
TABLE 88 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 236
TABLE 89 NOVARTIS: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 244
TABLE 90 NOVARTIS AG: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 245
TABLE 91 NOVARTIS AG: SEGMENTAL REVENUE OF ALCON LABORATORIES, (2012-2014) ($MN) 246
TABLE 92 NOVARTIS AG: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 247
TABLE 93 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 253
TABLE 94 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 254
TABLE 95 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 255
TABLE 96 CARL ZEISS AG: TOTAL SALES AND RandD EXPENSES (2012-2014) ($MN) 265
TABLE 97 CARL ZEISS: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN) 266
TABLE 98 CARL ZEISS: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN) 267
TABLE 99 ESSILOR: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 277
TABLE 100 ESSILOR INTERNATIONAL: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 278
TABLE 101 ESSILOR INTERNATIONAL: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 279
TABLE 102 HOYA CORPORATION: TOTAL REVENUE AND RandD EXPENSES (2012-2014) ($MN) 293
TABLE 103 HOYA CORPORATION: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN) 294
TABLE 104 HOYA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN) 295
TABLE 105 JOHNSON and JOHNSON: TOTAL REVENUE AND RandD EXPENSES (2012-2014) ($MN) 300
TABLE 106 JOHNSON and JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 301
TABLE 107 JOHNSON and JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 302
TABLE 108 STAAR SURGICAL COMPANY: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 314
TABLE 109 STAAR SURGICAL COMPANY: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 315
TABLE 110 STAAR SURGICAL COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN) 316
TABLE 111 TOPCON CORPORAION.: TOTAL SALES AND RandD EXPENSES (2012-2014) ($MN) 321
TABLE 112 TOPCON CORPORATION: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN) 322
TABLE 113 TOPCON CORPORATION: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN) 323

































LIST OF FIGURES

FIGURE 1 GLOBAL OPHTHALMOLOGY DEVICES MARKET SHARE AND REVENUE, BY REGION (2013-2021) 22
FIGURE 2 RESEARCH METHODOLOGY: OPHTHALMOLOGY DEVICES GLOBAL MARKET 33
FIGURE 3 OPHTHALMOLOGY DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 34
FIGURE 4 OPHTHALMOLOGY DEVICES MARKET: FORECASTING MODEL 35
FIGURE 5 OPHTHALMOLOGY DEVICES MARKET: MARKET BREAKDOWN and DATA TRIANGULATION 36
FIGURE 6 OPHTHALMOLOGY DEVICES MARKET SEGMENTATION 43
FIGURE 7 MARKET DYNAMICS 44
FIGURE 8 OPHTHALMOLOGY DEVICES MARKET:PATENT FILING BY MAJOR PLAYERS (2010-2015) 59
FIGURE 9 OPHTHALMOLOGY DEVICES MARKET:PATENT FILING BY SEGMENT, (2010-2015) 60
FIGURE 10 OPHTHALMOLOGY DEVICES MARKET: PORTER'S ANALYSIS 69
FIGURE 11 OPHTHALMOLOGY DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014 72
FIGURE 12 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2014 V'S 2021) ($MN) 79
FIGURE 13 GLOBAL OPHTHALMOLOGY DEVICE MARKET REVENUE, BY SURGERY (2014 V'S 2021) ($MN) 118
FIGURE 14 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION (2014 V'S 2021) ($MN) 148
FIGURE 15 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END USERS (2013 V'S 2021) ($MN) 163
FIGURE 16 GLOBAL OPHTHALMOLOGY DEVICES MARKET REVENUE, BY REGION (2013-2021) ($MN) 172
FIGURE 17 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, APPLICATION and END-USER OUTLOOK, (2014 V'S 2021) 176
FIGURE 18 EUROPEAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, APPLICATION and END-USER OUTLOOK, (2014 V'S 2021) 186
FIGURE 19 ASIA-PACIFIC OPHTHMOLOGY DEVICES MARKET SIZE, BY TYPE, PRODUCT, APPLICATION and END-USER OUTLOOK, (2014 V'S 2021) 196
FIGURE 20 ROW OPHTHMOLOGY DEVICES MARKET SIZE, BY TYPE, PRODUCT, APPLICATION and END-USER OUTLOOK, (2014 V'S 2021) 206
FIGURE 21 KEY GROWTH STRATEGIES, (2013-2015) 216
FIGURE 22 SWOT: ABBOTT LABORATORIES 242
FIGURE 23 SWOT: ALCON LABORATORIES. 251
FIGURE 24 SWOT: VALEANT PHARMACEUTICALS INTERNATIONAL 263
FIGURE 25 SWOT: CARL ZEISS 275
FIGURE 26 SWOT: ESSILOR INTERNATIONAL 285
FIGURE 27 SWOT: HAAG-STREIT AG 291
FIGURE 28 SWOT: HOYA CORPORATION 298
FIGURE 29 SWOT: JOHNSON and JOHNSON 305
FIGURE 30 SWOT: STAAR SURGICAL COMPANY 319
FIGURE 31 SWOT: TOPCON CORPORATION 327

?
LIST OF ACRONYMS

Acronym Expanded form
AAO America Academy of Ophthalmology
AAPOS American Association of Paediatric Ophthalmology and Strabismus
AIMDD Active Implantable Medical Device Directive
AMD Age Related Macular Degeneration
AMO Abbott Medical Optics
BandL Bausch and Lomb
CDC Centre for Disease Control and Development
CDRH Centre for Devices and Radiological Health
CDSCO Central Drug Standard Control Organization
CE Conformity Europeans
CFDA China Food and Drug Administration
CLAA Central Licensing Approval Authority
CLAO Contact Lens Association of Ophthalmologists
CMOs Contract Manufacturing Organization
CROs Contract Research Organizations
CTS Common Technical Specifications
DME Diabetic Macular Edema
DR Diabetic Retinopathy
DWFS Deconvolution Wave front Sensing
EIU Economist Intelligence Unit
EU European Union
FDA Food and Drug Administration
FFA Fundus Fluorescien Angiography
GMP Good Manufacturing Practice
GPOs Group Purchasing Organizations
GRF Glaucoma Research Foundation
HHS Department of Health and Human Services
HPO High Performance Optics
ICEH International Center for Eye Health
ICO International Council of Ophthalmology
IOL Intraocular Lenses
IOP Intraocular Pressure
JMDN Japan Medical Device Nomenclature
JOIA Japan Ophthalmic Instruments Association
LAL Light Adjustable Lens
LASEK Laser Assisted Sub-Epithelium Keratomileusis
LASIK Laser Assisted Insitu Keratomileusis
LATAM Latin America
LCD Liquid Crystal Display
LED Light Emitting Diodes
MAH Market Authorization Holder
MDD Medical Device Directive
MHLW Ministry of Health, Labor and Welfare
MIGS Minimal Invasive Glaucoma Surgery
MPF Medicare Physician Fee
OAG Open-Angle Glaucoma
OCT Optical Coherence Tomography
ODE Office of Device Evolution
OECD Organization of Economic Cooperation and Development
OEM Original Equipment Manufacturers
OVD Ophthalmic Viscoelastic Devices
PAL Pharmaceutical Affairs Law
PIOL Phakic Intraocular Lens
PMA Pre Market Approval
PMDA Pharmaceutical and Medical Devices Agency
PPACA Patient Protection and Affordable Care Act
PRK Photorefractive keratectomy
QS Quality System
RandD Research and Development
RCB Registered Certified Body
RK Radial Keratotomy
RLE Refractive Lens Exchange
ROP Retinopathy of Prematurity
RoW Rest of the World
SD-OCT Spectral Domain Optical Coherence Tomography
SEC Security and Exchange Commission
SFDA State Food and Drug Administration
SOE European Society of Ophthalmology
STED Summary Technical Document
U.S. United States of America
UK United Kingdom
UV Ultra-Violet
VEGF Vascular Endothelial Growth Factor
VST Vision Shaping Treatment
WHO World Health Organization

1


Companies Mentioned
ABBOTT LABORATORIES
CARL ZEISS AG ESSILOR INTERNATIONAL
HAAG-STREIT HOLDING AG
HOYA CORPORATION
JOHNSON and JOHNSON
NIDEK CO., LTD
NOVARTIS AG
STAAR SURGICAL COMPANY
TOPCON CORPORATION VALEANT PHARMACEUTICALS INTERNATIONAL, INC

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Glaucoma Therapeutics Market: Overview Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results into vision loss and blindness. The treatment for glaucoma ...

Ophthalmic Lasers Market by Product Type, Application, & End User - Global Forecast to 2021

Ophthalmic Lasers Market by Product Type, Application, & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The ophthalmic lasers market is projected to reach USD 1,245.4 million by 2021 from USD 970.2 million in 2016, at a CAGR of 5.1%. Increasing prevalence of ophthalmic disorders, increasing prevalence of ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.